Back
Zevra Therapeutics Stock Predictions
Google closes secret $20B deal with Apple to become iPhone's default search engine
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ZVRA
Zevra Therapeutics
Last Price:
$8.21
Seasonality Move:
-11.97%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Zevra Therapeutics Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 11% based on the past 9 years of stock performance.
-
Zevra Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Zevra Therapeutics Stock Undervalued?The current Zevra Therapeutics [ZVRA] share price is $8.01. The Score for ZVRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 11% based on the past 9 years of stock performance.
Zevra Therapeutics Stock Rating
Sell
37
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics overpriced?
-
Zevra Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.76
52-Week Low:
4.20
Prediction Charts
Market Cap:
433.5M
Price in USD:
8.01
Volume:
1.7M
Beta:
1.81
Technical Analysis
SMA50:
7.93
SMA100:
8.32
SMA200:
7.44
52-Wk Change:
37.16%
Stock Predictions
-
Is Zevra Therapeutics stock public?Yes, Zevra Therapeutics is a publicly traded company.
-
What is the Zevra Therapeutics stock quote today?The Zevra Therapeutics stock price is 8.01 USD today.
-
How to buy Zevra Therapeutics stock online?You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-3 | 8.05 | 7.34 | 8.09 | 7.31 |
| Mar-4 | 7.31 | 7.39 | 7.44 | 7.21 |
| Mar-5 | 7.38 | 7.70 | 7.72 | 7.33 |
| Mar-6 | 7.61 | 8.05 | 8.26 | 7.61 |
| Mar-7 | 8.04 | 8.10 | 8.19 | 7.87 |
| Mar-11 | 7.99 | 8.07 | 8.12 | 7.78 |
| Mar-12 | 8.02 | 7.92 | 8.30 | 7.32 |
| Mar-13 | 7.84 | 7.94 | 8.29 | 7.62 |
| Mar-14 | 7.96 | 8.31 | 8.49 | 7.77 |
| Mar-17 | 8.29 | 8.35 | 8.42 | 8.18 |
| Mar-18 | 8.27 | 7.97 | 8.40 | 7.96 |
| Mar-19 | 7.94 | 7.95 | 8.10 | 7.84 |
| Mar-20 | 7.88 | 8.01 | 8.09 | 7.81 |
| Mar-21 | 7.91 | 8.01 | 8.14 | 7.87 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.